Genomics plc, an analysis company developing algorithms, data resources, and software on genetic variation and human disease, has entered into a collaboration with Biogen to refine drug target selection through the use of sophisticated analysis of human genetic data.   Biogen will leverage findings from Genomics’ integrated database and analysis tools, which will be used to guide R&D regarding the likely efficacy and safety of its intended drug targets.   Genomics’ platform combines algo...